Skip to main content
Log in

Comparative Analysis of Proteins with Stimulating Activity on Ovarian Estradiol Biosynthesis from Four Different Dioscorea Species in vitro Using Both Phenotypic and Target-based Approaches: Implication for Treating Menopause

  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

Rhizomes of Dioscorea species are traditionally used for relieving menopausal syndromes in Chinese medicine. The estrogen-stimulating bioactive principles have been demonstrated in our previous study. In this study, the estrogen-stimulating effects of proteins isolated from four Dioscorea species [D. alata L. (DA), D. zingiberensis C.H. Wright (DH), D. collettii var. hypoglauca (Palib.) S.J. Pei & C.T. Ting (DH), and D. oppositifolia L. (DO)] have been investigated and compared. Microscopic authentication of four Dioscorea species was performed by using paraffin and powder sections of the rhizomes. The potential bioactive proteins of four Dioscorea species have been rapidly isolated by using a DOI-antibody affinity column chromatography on immobilized antibodies against on estradiol-stimulating protein from DO (DOI), and their bioactivity has been rapidly confirmed and compared by phenotypic (i.e., estradiol-stimulating effect) and target-based (i.e., STAR, aromatase, estrogen receptors) screening approaches. The estrogen-stimulating activity of bioactive proteins from DO is the highest. In addition, bioactive proteins from DO upregulated the estradiol-metabolizing enzymes (aromatase and steroidogenic acute regulatory protein). Meanwhile, bioactive proteins from DA, DH and DO upregulated estrogen receptor β (ERβ). All bioactive proteins did not change the expression of estrogen receptor β (ERα). The estrogen-stimulating bioactive proteins isolated from DO increased biosynthesis of estradiol and upregulated the protein expression of aromatase, steroidogenic acute regulatory protein, and ERβ. The results scientifically support the traditional use of DO in Chinese medicine for relieving menopausal syndrome. Besides, proteins from DA and DZ could also upregulate the translational levels of ERβ, and potentially reducing the risk of ovarian cancer, which also support the clinical use of them for treating female aging disorder.

Comparative Analysis of DOI-like Proteins with Stimulating Activity on Ovarian Estradiol Biosynthesis from Four Different Dioscorea Species in vitro

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

DA:

D. alata L.

DZ:

D. zingiberensis C.H. Wright

DH:

D. collettii var. hypoglauca (Palib.) S.J. Pei & C.T. Ting

DO:

D. oppositifolia L

E2 :

17β-estradiol

CYP19:

aromatase

StAR:

steroidogenic acute regulatory protein

ERα:

estrogen receptor alpha

ERβ:

estrogen receptor beta

References

  1. Burger, H., et al. (2007). Nomenclature and endocrinology of menopause and perimenopause. Expert Review of Neurotherapeutics, 7(11 Suppl), S35–S43.

    Article  Google Scholar 

  2. Shuster, L. T., et al. (2010). Premature menopause or early menopause: long-term health consequences. Maturitas, 65(2), 161–166.

    Article  Google Scholar 

  3. Lacey, J. V., Jr., et al. (2002). Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA, 288(3), 334–341.

    Article  CAS  Google Scholar 

  4. Wang, S. W., et al. (2015). Network pharmacological identification of active compounds and potential actions of Erxian decoction in alleviating menopause-related symptoms. Chinese Medicine, 10, 19.

    Article  Google Scholar 

  5. Wong, K. L., et al. (2015). A novel, stable, estradiol-stimulating, osteogenic yam protein with potential for the treatment of menopausal syndrome. Scientific Reports, 5, 10179.

    Article  Google Scholar 

  6. Sze, S. C. W., et al. (2011). Effects of Erxian decoction, a Chinese medicinal formulation, on serum lipid profile in a rat model of menopause. Chinese Medicine, 6, 40.

    Article  CAS  Google Scholar 

  7. Sze, S. C. W., et al. (2009). A novel mechanism: Erxian Decoction, a Chinese medicine formula, for relieving menopausal syndrome. Journal of Ethnopharmacology, 123(1), 27–33.

    Article  CAS  Google Scholar 

  8. Shang, Y. (2006). Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nature Reviews Cancer, 6(5), 360–368.

    Article  CAS  Google Scholar 

  9. Dubik, D., & Shiu, R. P. (1992). Mechanism of estrogen activation of c-myc oncogene expression. Oncogene, 7(8), 1587–1594.

    CAS  Google Scholar 

  10. Stettner, M., et al. (2007). The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment. Molecular Cancer Therapeutics, 6(10), 2626–2633.

    Article  CAS  Google Scholar 

  11. Pearce, S. T., & Jordan, V. C. (2004). The biological role of estrogen receptors alpha and beta in cancer. Critical Reviews in Oncology/Hematology, 50(1), 3–22.

    Article  Google Scholar 

  12. Brandenberger, A. W., Tee, M. K., & Jaffe, R. B. (1998). Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues. Journal of Clinical Endocrinology and Metabolism, 83(3), 1025–1028.

    CAS  Google Scholar 

  13. Simpson, E. R., et al. (1994). Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrine Reviews, 15(3), 342–355.

    CAS  Google Scholar 

  14. Bulun, S. E., et al. (1999). Aromatase in aging women. Seminars in Reproductive Endocrinology, 17(4), 349–358.

    Article  CAS  Google Scholar 

  15. Gosden, R. G., & Faddy, M. J. (1994). Ovarian aging, follicular depletion, and steroidogenesis. Experimental Gerontology, 29(3–4), 265–274.

    Article  CAS  Google Scholar 

  16. Li, W. (2006). The clinical study of treating peripheral menopause syndrome (PMS) with the Decoction of Bu-Shen-An-Geng. In Chinese gynecology. Shandong University of Traditional Chinese Medicine.

  17. Zhou, J., Gan, B. L., Wei, G. N., Chen, J. M., & Qin, L. (2009). Experimental research of Angeng Recipe on climacteric rats. Chinese Traditional Patent Medicine, 31(9), 3.

    Google Scholar 

  18. Komesaroff, P. A., et al. (2001). Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric, 4(2), 144–150.

    Article  CAS  Google Scholar 

  19. Chinese Pharmacopoeia Commission. (2015). Pharmacopoeia of the People’s Republic of China (Vol. I). Beijing: People’s Medical Publishing House.

    Google Scholar 

  20. Liu, L., et al. (2010). Biotransformation of steriodal saponins in Dioscorea zingiberensis C. H. Wright to diosgenin by Trichoderma harzianum. Applied Microbiology and Biotechnology, 85(4), 933–940.

  21. Wei, M., et al. (2016). Low pressure steam expansion pretreatment as a competitive approach to improve diosgenin yield and the production of fermentable sugar from Dioscorea zingiberensis C.H. Wright. Bioresource Technology, 206, 50–56.

  22. Hu, K., et al. (1999). A new pregnane glycoside from Dioscorea collettii var. hypoglauca. Journal of Natural Products, 62(2), 299–301.

    Article  CAS  Google Scholar 

  23. Cheng, W. Y., Kuo, Y. H., & Huang, C. J. (2007). Isolation and identification of novel estrogenic compounds in yam tuber (Dioscorea alata Cv. Tainung No. 2). Journal of Agricultural and Food Chemistry, 55(18), 7350–7358.

    Article  CAS  Google Scholar 

  24. Hsu, F. L., et al. (2002). Both dioscorin, the tuber storage protein of yam (Dioscorea alata cv. Tainong No. 1), and its peptic hydrolysates exhibited angiotensin converting enzyme inhibitory activities. Journal of Agricultural and Food Chemistry, 50(21), 6109–6113.

    Article  CAS  Google Scholar 

  25. Lin, P. L., et al. (2009). Yam storage protein dioscorins from Dioscorea alata and Dioscorea japonica exhibit distinct immunomodulatory activities in mice. Journal of Agricultural and Food Chemistry, 57(11), 4606–4613.

    Article  CAS  Google Scholar 

  26. Ulbricht, C., et al. (2003). Wild yam (Dioscoreaceae). Journal of Herbal Pharmacotherapy, 3(4), 77–91.

    Article  Google Scholar 

  27. Patel, K., Gadewar, M., Tahilyani, V., & Patel, D. K. (2012). A review on pharmacological and analytical aspects of diosgenin: a concise report. Natural Products and Bioprospecting, 2, 46–52.

    Article  CAS  Google Scholar 

  28. Marker, R. E. (1940). The preparation of testosterone and related compounds from sarsasapogenin and diosgenin. Journal of the American Chemical Society, 62, 2543–2547.

    Article  CAS  Google Scholar 

  29. Olofson, R. A., & Gortler, L. B. (1999). The “marker degradation” and creation of the Mexican steroid hormone industry 1938–1945. Washington: The American Chemical Society and the Sociedad Química de México.

    Google Scholar 

  30. Wu, W. H., et al. (2005). Estrogenic effect of yam ingestion in healthy postmenopausal women. Journal of the American College of Nutrition, 24(4), 235–243.

    Article  CAS  Google Scholar 

  31. Sze, S. C. W, Wong, K. L., Tong, Y., Zhang, Y. B., & Cheung, H. P. (2013). Novel bioactive protein isolated from Chinese yam and uses thereof. In USPTO (Ed.), USPTO, USA. Patent Pub. No.:US20130217626A1. Pub. Date: Aug. 22, 2013.

  32. Sze, S. C. W., Wong, K. L., Tong, Y., Zhang, Y. B., & Cheung, H. P. (2013). Novel bioactive protein isolated from Chinese yam and uses thereof. In P. C. Treaty (Ed.). Patent Pub. No.:WO/2013/023617. Pub. Date: Feb. 21, 2013.

  33. Srivastava, V. K., et al. (2005). Effect of ethanol on follicle stimulating hormone-induced steroidogenic acute regulatory protein (StAR) in cultured rat granulosa cells. Alcohol, 37(2), 105–111.

    Article  CAS  Google Scholar 

  34. Ruzin, S. E. (1999). Plant microtechnique and microscope. New York: Oxford University Press.

    Google Scholar 

  35. Campbell, K. L. (1979). Ovarian granulosa cells isolated with EGTA and hypertonic sucrose: cellular integrity and function. Biology of Reproduction, 21(4), 773–786.

    Article  CAS  Google Scholar 

  36. Lovekamp-Swan, T., & Chaffin, C. L. (2005). The peroxisome proliferator-activated receptor gamma ligand troglitazone induces apoptosis and p53 in rat granulosa cells. Molecular and Cellular Endocrinology, 233(1–2), 15–24.

    Article  CAS  Google Scholar 

  37. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227(5259), 680–685.

    Article  CAS  Google Scholar 

  38. Lou, Z. Q., & Qin, B. (1995). Species systematization and quality evaluation of commonly used Chinese traditional medicine (Vol. 2). Beijing: Beijing University Medical Press.

    Google Scholar 

  39. State of Administration of Traditional Chinese Medicine. (1999). Chinese materia medica. Shanghai: Shanghai Science and Technology Press.

    Google Scholar 

  40. Commission, C. P. (2009). An illustrated handbook on microscopic identification of Chinese crude drugs for Chinese pharmacopoeia. Beijing: People’s Medical Publishing House.

    Google Scholar 

  41. Chinese Pharmacopoeia Commission. (2010). Chinese pharmacopoeia I. Beijing: Chemical Industry Press.

    Google Scholar 

  42. The Ministry of Health Pharmacopoeia Committee. (1999). A colored atlas of microscopic identification of Chinese material medica in powdered from as specified in pharmacopoeia of the People’s Republic of China. Guangdong: Guangdong Science and Technology Press.

    Google Scholar 

  43. Hsueh, A. J., et al. (1984). Hormonal regulation of the differentiation of cultured ovarian granulosa cells. Endocrine Reviews, 5(1), 76–127.

    Article  CAS  Google Scholar 

  44. Son, I. S., et al. (2007). Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol fed rats. Bioscience Biotechnology and Biochemistry, 71(12), 3063–3071.

    Article  CAS  Google Scholar 

  45. Araghiniknam, M., et al. (1996). Antioxidant activity of dioscorea and dehydroepiandrosterone (DHEA) in older humans. Life Sciences, 59(11), PL147–PL157.

    Article  CAS  Google Scholar 

  46. Mueller, S. O., & Korach, K. S. (2001). Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout mice. Current Opinion in Pharmacology, 1(6), 613–619.

    Article  CAS  Google Scholar 

  47. Brekelmans, C. T. (2003). Risk factors and risk reduction of breast and ovarian cancer. Current Opinion in Obstetrics and Gynecology, 15(1), 63–68.

    Article  Google Scholar 

  48. Gambacciani, M., et al. (2003). Hormone replacement therapy and endometrial, ovarian and colorectal cancer. Best Practice & Research Clinical Endocrinology & Metabolism, 17(1), 139–147.

    Article  CAS  Google Scholar 

  49. Riman, T., et al. (2002). Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. Journal of the National Cancer Institute, 94(7), 497–504.

    Article  CAS  Google Scholar 

  50. Hillier, S. G., et al. (1998). Expression of oestrogen receptor alpha and beta in cultured human ovarian surface epithelial cells. Molecular Human Reproduction, 4(8), 811–815.

    Article  CAS  Google Scholar 

  51. Pujol, P., et al. (1998). Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Research, 58(23), 5367–5373.

    CAS  Google Scholar 

  52. Rutherford, T., et al. (2000). Absence of estrogen receptor-beta expression in metastatic ovarian cancer. Obstetrics and Gynecology, 96(3), 417–421.

    CAS  Google Scholar 

  53. Fujimura, M., et al. (2001). Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma. American Journal of Surgical Pathology, 25(5), 667–672.

    Article  CAS  Google Scholar 

  54. Talukder, M. M., & Shiong, S. C. (2015). Stabilization of chromobacterium viscosum lipase (CVL) against ultrasound inactivation by the pretreatment with polyethylene glycol (PEG). Applied Biochemistry and Biotechnology, 177(8), 1742–1752.

    Article  CAS  Google Scholar 

  55. Wang, X., Qian, C., & Yu, X. (2014). Synthesis of nano-hydroxyapatite via microbial method and its characterization. Applied Biochemistry and Biotechnology, 173(4), 1003–1010.

    Article  CAS  Google Scholar 

  56. Wong, K. L., et al. (2014). Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential. Chinese Medicine, 9, 19.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. C. W. Sze.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Funding

We thank the Innovation and Technology Support Programme of the government of Hong Kong Special Administrative Region for the generous support of this project (Project code: ITS/262/09FP) and Seed Funding for Basic Research of the University of Hong Kong (Project code: 201211159146; 201011159213).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lu, J., Wong, R.N.S., Zhang, L. et al. Comparative Analysis of Proteins with Stimulating Activity on Ovarian Estradiol Biosynthesis from Four Different Dioscorea Species in vitro Using Both Phenotypic and Target-based Approaches: Implication for Treating Menopause. Appl Biochem Biotechnol 180, 79–93 (2016). https://doi.org/10.1007/s12010-016-2084-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-016-2084-x

Keywords

Navigation